87 related articles for article (PubMed ID: 9191402)
21. Modulation of the immune response in multiple sclerosis: production of monoclonal antibodies specific to HLA/myelin basic protein.
Puri J; Arnon R; Gurevich E; Teitelbaum D
J Immunol; 1997 Mar; 158(5):2471-6. PubMed ID: 9036999
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules.
Klohe EP; Watts R; Bahl M; Alber C; Yu WY; Anderson R; Silver J; Gregersen PK; Karr RW
J Immunol; 1988 Sep; 141(6):2158-64. PubMed ID: 2459201
[TBL] [Abstract][Full Text] [Related]
23. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
[TBL] [Abstract][Full Text] [Related]
24. Rules governing peptide-class II MHC molecule interactions.
Hammer J; Nagy ZA; Sinigaglia F
Behring Inst Mitt; 1994 Jul; (94):124-32. PubMed ID: 7998906
[No Abstract] [Full Text] [Related]
25. HLA-DR-, MB- and novel DC-related determinants restrict purified protein derivative of tuberculin (PPD)-stimulated human T cell proliferation.
Pawelec G; Schneider EM; Müller C; Wernet P
Eur J Immunol; 1985 Jan; 15(1):12-7. PubMed ID: 2578396
[TBL] [Abstract][Full Text] [Related]
26. A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DR-restricted CD4(+) T lymphocytes.
Rajnavölgyi E; Nagy N; Thuresson B; Dosztányi Z; Simon A; Simon I; Karr RW; Ernberg I; Klein E; Falk KI
Int Immunol; 2000 Mar; 12(3):281-93. PubMed ID: 10700463
[TBL] [Abstract][Full Text] [Related]
27. Invariant-cognate peptide exchange restores class II dimer stability in HLA-DM mutants.
Monji T; McCormack AL; Yates JR; Pious D
J Immunol; 1994 Nov; 153(10):4468-77. PubMed ID: 7525705
[TBL] [Abstract][Full Text] [Related]
28. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
29. Delineation of several DR-restricted tetanus toxin T cell epitopes.
Demotz S; Lanzavecchia A; Eisel U; Niemann H; Widmann C; Corradin G
J Immunol; 1989 Jan; 142(2):394-402. PubMed ID: 2463305
[TBL] [Abstract][Full Text] [Related]
30. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
31. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
32. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
Karp DR; Long EO
J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
[TBL] [Abstract][Full Text] [Related]
33. Localization of MHC class II/human cartilage glycoprotein-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodies.
Steenbakkers PG; Baeten D; Rovers E; Veys EM; Rijnders AW; Meijerink J; De Keyser F; Boots AM
J Immunol; 2003 Jun; 170(11):5719-27. PubMed ID: 12759455
[TBL] [Abstract][Full Text] [Related]
34. Recognition of the HLA class II-peptide complex by T-cell receptor: reversal of major histocompatibility complex restriction of a T-cell clone by a point mutation in the peptide determinant.
Rothbard JB; Busch R; Lechler R; Trowsdale J; Lamb JR
Philos Trans R Soc Lond B Biol Sci; 1989 Jun; 323(1217):553-64. PubMed ID: 2474172
[TBL] [Abstract][Full Text] [Related]
35. Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1.
Hurley JM; Shimonkevitz R; Hanagan A; Enney K; Boen E; Malmstrom S; Kotzin BL; Matsumura M
J Exp Med; 1995 Jun; 181(6):2229-35. PubMed ID: 7760008
[TBL] [Abstract][Full Text] [Related]
36. Amino acid substitutions in the putative MHC class II "dimer of dimers" interface inhibit CD4+ T cell activation.
Lindstedt R; Monk N; Lombardi G; Lechler R
J Immunol; 2001 Jan; 166(2):800-8. PubMed ID: 11145653
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of HLA-DR antigen expression in phytohemagglutinin-activated T cells in man. Requirement of T cell recognition of self HLA-DR antigen expressed on the surface of monocytes.
Moriya N; Sanjoh K; Yokoyama S; Hayashi T
J Immunol; 1987 Nov; 139(10):3281-6. PubMed ID: 3500214
[TBL] [Abstract][Full Text] [Related]
38. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
[TBL] [Abstract][Full Text] [Related]
39. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen.
Gay D; Maddon P; Sekaly R; Talle MA; Godfrey M; Long E; Goldstein G; Chess L; Axel R; Kappler J
Nature; 1987 Aug 13-19; 328(6131):626-9. PubMed ID: 3112582
[TBL] [Abstract][Full Text] [Related]
40. Melanosomal targeting sequences from gp100 are essential for MHC class II-restricted endogenous epitope presentation and mobilization to endosomal compartments.
Lepage S; Lapointe R
Cancer Res; 2006 Feb; 66(4):2423-32. PubMed ID: 16489049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
